Literature DB >> 22679619

Primary endobronchial plasmacytoma involving local lymph nodes and presenting with rare immunoglobulin G lambda monoclonal gammopathy.

Sen Wei1, Xin Li, Zuoqing Song, Honglin Zhao, Xiaomin Qiu, Lei Gong, Jun Chen, Qinghua Zhou.   

Abstract

Extramedullary plasmacytoma occurring as a primary pulmonary lesion is rare. The present report describes a 42-year-old Chinese man diagnosed with primary pulmonary plasmacytoma following left lower lobectomy. Of note, an extremely rare immunoglobulin G lambda paraprotein was documented in the patient's serum by immunofixation electrophoresis. The patient has been well, showing no local recurrence or multifocal disease during a 15-month follow-up.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22679619      PMCID: PMC3418101          DOI: 10.1155/2012/968254

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  11 in total

1.  Primary pulmonary plasmacytoma with immunoglobulin G/lambda light chain monoclonal gammopathy.

Authors:  Chin-Chih Chang; Yih-Leong Chang; Li-Na Lee; Yung-Chie Lee
Journal:  J Thorac Cardiovasc Surg       Date:  2006-10       Impact factor: 5.209

2.  Primary pulmonary plasmacytoma.

Authors:  Gulvahid Shaikh; Rahul Sehgal; Anshu Mehrishi; Ashok Karnik
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

Review 3.  Solitary plasmacytoma of the lung with light chain extracellular deposits: a case report and review of the literature.

Authors:  F Piard; N Yaziji; O Jarry; M Assem; L Martin; A Bernard; J P Jacquot; E Justrabo
Journal:  Histopathology       Date:  1998-04       Impact factor: 5.087

4.  Endobronchial extramedullary plasmacytoma. Report of one case.

Authors:  A Terzi; G Furlan; M Zannoni; A Adovasio; A Gorla
Journal:  Lung Cancer       Date:  1996-12       Impact factor: 5.705

5.  Clinical outcome of extramedullary plasmacytoma.

Authors:  P Galieni; M Cavo; A Pulsoni; G Avvisati; C Bigazzi; S Neri; U Caliceti; M Benni; S Ronconi; F Lauria
Journal:  Haematologica       Date:  2000-01       Impact factor: 9.941

6.  Primary pulmonary plasmacytoma: a case report.

Authors:  J N Wise; R F Schaefer; R C Read
Journal:  Chest       Date:  2001-10       Impact factor: 9.410

7.  Laser treatment of endobronchial extramedullary plasmacytoma.

Authors:  L E Brackett; J R Myers; C B Sherman
Journal:  Chest       Date:  1994-10       Impact factor: 9.410

Review 8.  Pulmonary plasmacytomas: a clinicopathologic and immunohistochemical study of five cases.

Authors:  M N Koss; L Hochholzer; C A Moran; G Frizzera
Journal:  Ann Diagn Pathol       Date:  1998-02       Impact factor: 2.090

Review 9.  Primary pulmonary plasmacytoma.

Authors:  G Joseph; M Pandit; L Korfhage
Journal:  Cancer       Date:  1993-02-01       Impact factor: 6.860

Review 10.  Primary solitary endobronchial plasmacytoma.

Authors:  Evgeny Edelstein; Anthony A Gal; Karen P Mann; Joseph I Miller; Kamal A Mansour
Journal:  Ann Thorac Surg       Date:  2004-10       Impact factor: 4.330

View more
  4 in total

Review 1.  Primary pulmonary plasmacytoma: a case report introduction.

Authors:  Si Nie; De-Chang Peng; Hong-Han Gong; Cheng-Long Ye; Xiao Nie; Hai-Jun Li
Journal:  World J Surg Oncol       Date:  2016-08-04       Impact factor: 2.754

2.  Primary pulmonary plasmacytoma presenting with rare IgG lambda monoclonal gammopathy.

Authors:  Yasmin Rahim; Farrukh Zia Tareen; Rashida Ahmed; Javaid Ahmed Khan
Journal:  BMJ Case Rep       Date:  2019-03-06

3.  Non-secretory multiple myeloma expressed as multiple extramedullary plasmacytoma with an endobronchial lesion mimicking metastatic cancer: A case report.

Authors:  Seul Bi Lee; Chi Young Park; Hee Jeong Lee; Ran Hong; Woo Shin Kim; Sang-Gon Park
Journal:  World J Clin Cases       Date:  2022-08-06       Impact factor: 1.534

4.  Primary pulmonary plasmacytoma accompanied by overlap syndrome: A case report and review of the literature.

Authors:  Yi Zhou; Xiao-Hong Wang; Shuang-Shuang Meng; Hui-Chao Wang; Yu-Xia Li; Rui Xu; Xu-Hong Lin
Journal:  World J Clin Cases       Date:  2020-10-26       Impact factor: 1.337

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.